Marizyme, Inc. (MRZM) Financial Statements (2024 and earlier)

Company Profile

Business Address 555 HERITAGE DRIVE
JUPITER, FL 33458
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2053305111,1822,0453,173
Cash and cash equivalents2053305111,1822,0453,173
Receivables73788854539
Inventory, net of allowances, customer advances and progress billings14017721625126816
Inventory14017721625126816
Prepaid expense6061,2591,126840235470
Other undisclosed current assets343515141321
Total current assets:1,0591,8791,9552,3422,6143,688
Noncurrent Assets
Operating lease, right-of-use asset1,2941,3901,4851,5761,6671,098
Property, plant and equipment131313131313
Intangible assets, net (including goodwill)34,44534,65534,86659,42659,63659,847
Goodwill7,1917,1917,1917,1917,1917,191
Intangible assets, net (excluding goodwill)27,25427,46527,67552,23552,44652,656
Prepaid expense      
Deposits noncurrent assets    303030
Other undisclosed noncurrent assets171333369339339339
Total noncurrent assets:35,92336,39136,73261,38461,68561,326
TOTAL ASSETS:36,98138,27038,68863,72664,30065,014
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,0381,8731,365848617823
Other undisclosed accounts payable and accrued liabilities2,0381,8731,365848617823
Debt12,6005,6391,133214241285
Derivative instruments and hedges, liabilities5,462     
Due to related parties 123224271
Other liabilities  89    
Other undisclosed current liabilities722426423421418277
Total current liabilities:20,8228,0272,9221,6061,5001,656
Noncurrent Liabilities
Long-term debt and lease obligation307  2,80415,36312,604
Long-term debt, excluding current maturities307  1,64914,11411,783
Liabilities, other than long-term debt8665,7885,8854,9244,4243,822
Operating lease, liability8669641,0621,1561,249821
Derivative instruments and hedges, liabilities  4,8244,8244,9244,4243,822
Other undisclosed noncurrent liabilities7,7179,22312,45913,4441,6641,678
Total noncurrent liabilities:8,89015,01118,34421,17221,45018,104
Total liabilities:29,71223,03821,26622,77822,95119,760
Equity
Equity, attributable to parent7,27015,23217,42240,94841,34945,255
Common stock454141414141
Additional paid in capital116,345103,735103,371103,332102,18099,162
Accumulated deficit(109,120)(88,544)(85,989)(62,425)(60,872)(53,948)
Total equity:7,27015,23217,42240,94841,34945,255
TOTAL LIABILITIES AND EQUITY:36,98138,27038,68863,72664,30065,014

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues185129967662 
Cost of revenue(50)(39)    
Other undisclosed gross profit   (54)   
Gross profit:13590417662 
Operating expenses(4,939)(2,223)(26,535)(2,309)(4,664)(3,995)
Operating loss:(4,804)(2,133)(26,494)(2,233)(4,602)(3,995)
Nonoperating income (expense)(15,772)(422)2,929680(2,322)(2,130)
Interest and debt expense(685)     
Other undisclosed income from continuing operations before equity method investments, income taxes   338   
Loss from continuing operations:(21,261)(2,555)(23,226)(1,553)(6,924)(6,125)
Loss before gain (loss) on sale of properties:(1,553)(6,924)(6,125)
Net loss:(21,261)(2,555)(23,226)(1,553)(6,924)(6,125)
Other undisclosed net income (loss) attributable to parent685 (338)   
Net loss available to common stockholders, diluted:(20,576)(2,555)(23,564)(1,553)(6,924)(6,125)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(21,261)(2,555)(23,226)(1,553)(6,924)(6,125)
Comprehensive loss, net of tax, attributable to parent:(21,261)(2,555)(23,226)(1,553)(6,924)(6,125)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: